Andre N. Sofair, MD, MPH
Professor of Medicine (General Medicine) and of Epidemiology of Microbial DiseasesDownloadHi-Res Photo
Cards
Appointments
General Internal Medicine
Primary
Epidemiology of Microbial Diseases
Secondary
Contact Info
About
Titles
Professor of Medicine (General Medicine) and of Epidemiology of Microbial Diseases
Biography
Dr. Andre Sofair is a Professor in the Department of Internal Medicine at the Yale Medical School and holds a secondary appointment in the School of Public Health’s Department of Epidemiology of Microbial Diseases. He went to medical school at the Albert Einstein College of Medicine (1986) and completed his Master’s in Public Health at the Yale School of Public Health in 1997. He is an attending physician and Firm Chief at Yale New-Haven Hospital. He is also a lead organizer for the medical chief residency program at the University of Rwanda. In addition to leading many studies in hepatitis and clinical care, he has lectured widely on biomedical ethics and eugenic sterilization. He serves as co-director of the viral hepatitis clinic at the St. Raphael Campus.
Appointments
General Internal Medicine
ProfessorPrimaryEpidemiology of Microbial Diseases
ProfessorSecondary
Other Departments & Organizations
Education & Training
- MPH
- Yale School of Medicine (1997)
- MD
- Albert Einstein College of Medicine (1986)
- BA
- Cornell University, Biology (1982)
- Resident
- Yale-New Haven Hospital
Research
Overview
Medical Subject Headings (MeSH)
Communicable Diseases, Emerging; Hepatitis C; Infectious Disease Medicine; Internal Medicine; Liver
Research at a Glance
Yale Co-Authors
Frequent collaborators of Andre N. Sofair's published research.
Emilie Egger
Joseph Donroe, MD, MPH
Publications
2024
Clinical Reasoning: Perspectives of Expert Clinicians on Reasoning Through Complex Clinical Cases
Donroe J, Egger E, Soares S, Sofair A. Clinical Reasoning: Perspectives of Expert Clinicians on Reasoning Through Complex Clinical Cases. Cureus 2024, 16: e51696. PMID: 38313894, PMCID: PMC10838525, DOI: 10.7759/cureus.51696.Peer-Reviewed Original ResearchAltmetricConceptsComplex clinical casesClinical casesExpert cliniciansPrimary care physiciansDiagnostic errorsClinical reasoningCare physiciansSemi-structured guideCore clinical skillsMost doctorsComplex casesPatient's bedsideStudy institutionPatient contextPhysiciansClinical skillsCliniciansClinical reasoning strategiesBedsideClinical reasoning skillsThematic analysis
2002
Comparison of Visual and Spectrophotometric Methods of Broth Microdilution MIC End Point Determination and Evaluation of a Sterol Quantitation Method for In Vitro Susceptibility Testing of Fluconazole and Itraconazole against Trailing and Nontrailing Candida Isolates
Arthington-Skaggs BA, Lee-Yang W, Ciblak MA, Frade JP, Brandt ME, Hajjeh RA, Harrison LH, Sofair AN, Warnock A. Comparison of Visual and Spectrophotometric Methods of Broth Microdilution MIC End Point Determination and Evaluation of a Sterol Quantitation Method for In Vitro Susceptibility Testing of Fluconazole and Itraconazole against Trailing and Nontrailing Candida Isolates. Antimicrobial Agents And Chemotherapy 2002, 46: 2477-2481. PMID: 12121921, PMCID: PMC127334, DOI: 10.1128/aac.46.8.2477-2481.2002.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsEnd pointSterol quantitation methodActive population-based surveillanceCandida sppPopulation-based surveillanceVisual end pointMIC end pointsC. albicans isolatesAzole antifungal agentsComparison of VisualClinical Laboratory StandardsBloodstream isolatesVitro Susceptibility TestingCandida isolatesSusceptibility testingItraconazoleAlbicans isolatesFluconazoleMIC resultsNational CommitteeVivo outcomesAntifungal agentsGrowth inhibitionC. tropicalisLaboratory StandardsSurveillance for Unexplained Deaths and Critical Illnesses
Hajjeh RA, Relman D, Cieslak PR, Sofair AN, Passaro D, Flood J, Johnson J, Hacker JK, Shieh WJ, Hendry RM, Nikkari S, Ladd-Wilson S, Hadler J, Rainbow J, Tappero JW, Woods CW, Conn L, Reagan S, Zaki S, Perkins BA, Deaths F, Group C. Surveillance for Unexplained Deaths and Critical Illnesses. Emerging Infectious Diseases 2002, 8: 145-153. PMID: 11897065, PMCID: PMC2732455, DOI: 10.3201/eid0802.010165.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCritical illnessMedian ageInfectious causesUnexplained deathEmerging Infections Program sitesPatients' median ageCommon clinical presentationPopulation-based surveillanceYears of ageClinical presentationEpidemiologic featuresPolymerase chain reaction-based methodSerologic testsHealthy personsDiagnostic capacityReaction-based methodsRoutine testingIllnessDeathCauseAgeSurveillanceProgram sitesSyndromeEtiologyHepatitis C. Part 2. Consultant
Sofair, AN. Hepatitis C. Part 2. Consultant. 2002 42(4): 465-473.Peer-Reviewed Original ResearchHepatitis C. Part 1.
Sofair, AN. Hepatitis C. Part 1. Consultant. 2002 42(2): 157-161.Peer-Reviewed Original Research
2001
Anthrax-what you-and your patients-need to know now.
Bia, F. and Sofair, AN. Anthrax-what you-and your patients-need to know now. Consultant. 2001 41(14): 1797-1805.Peer-Reviewed Original Research
Clinical Care
Overview
Clinical Specialties
Internal Medicine
Board Certifications
Internal Medicine
- Certification Organization
- AB of Internal Medicine
- Latest Certification Date
- 2021
- Original Certification Date
- 1990
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileNews
News
Get In Touch
Contacts
Academic Office Number
Appointment Number
Clinic Fax Number
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.